webinar register page

Webinar banner
How the RECOVER Initiative Will Impact People with ME/CFS: A Conversation with NINDS Director Walter J. Koroshetz, M.D.
The symptoms of Long Covid can be indistinguishable from those typical of the illness known as myalgic encephalomyelitis (also referred to as chronic fatigue syndrome or ME/CFS), which is often triggered by an infection. As Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief medical advisor to the president, has noted, “Even after you clear the virus, there are post-viral symptoms, and it’s extraordinary how many people have a post-viral syndrome that’s very strikingly similar to ME/CFS. They just don’t get back to normal energy or normal feeling of good health.”
The National Institutes of Health (NIH) recently announced the $1.15 billion RECOVER initiative, designed to understand, prevent, and treat PASC, including Long COVID. (PASC stands for post-acute sequelae of SARS-CoV-2 and is a term scientists are using to study the potential consequences of a SARS-CoV-2 infection.)
Join Solve M.E. President and CEO Oved Amitay in conversation with NIH representative Walter J. Koroshetz, M.D., director of the National Institute of Neurological Disorders and Stroke (NINDS), as they discuss the ways in which RECOVER could impact the study and treatment of ME/CFS, and how you can get involved.

Nov 18, 2021 01:00 PM in Pacific Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Solve ME.